At the AACC show 2016
October 2016—ET Healthcare presented two posters at the meeting. Data from the abstract “A whole blood high-sensitivity cardiac troponin assay for POCT” showed that the Pylon cTnl assay met the definition of a fourth-generation high-sensitivity cardiac troponin I assay, with less than 10 percent CV at the 99th percentile and detection in greater than 95 percent of the reference population. The abstract is at www.bit.ly/pylonctnl-assay. The second abstract, “A novel point-of-care immunoassay delivering clinical lab performance” concluded that Pylon meets clinical lab performance standards for sensitivity, precision, and range and that small sample volumes and whole blood further facilitate point-of-care testing. This abstract is at www.bit.ly/pylon-assay.
ET Healthcare, 650-800-7651